nodes	percent_of_prediction	percent_of_DWPC	metapath
Niclosamide—STAT3—neck—salivary gland cancer	0.00948	0.311	CbGeAlD
Niclosamide—STAT3—Interleukin-11 Signaling Pathway—MAP2K2—salivary gland cancer	0.0076	0.00784	CbGpPWpGaD
Niclosamide—STAT3—Kit receptor signaling pathway—FOXO3—salivary gland cancer	0.00737	0.0076	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—HIST1H1E—salivary gland cancer	0.00723	0.00746	CbGpPWpGaD
Niclosamide—STAT3—TSLP Signaling Pathway—MAP2K2—salivary gland cancer	0.00721	0.00744	CbGpPWpGaD
Niclosamide—STAT3—connective tissue—salivary gland cancer	0.0068	0.223	CbGeAlD
Niclosamide—STAT3—Signaling events mediated by Stem cell factor receptor (c-Kit)—MAP2K2—salivary gland cancer	0.00676	0.00697	CbGpPWpGaD
Niclosamide—STAT3—IL-7 Signaling Pathway—CCND1—salivary gland cancer	0.00657	0.00678	CbGpPWpGaD
Niclosamide—STAT3—IL2-mediated signaling events—MAP2K2—salivary gland cancer	0.00646	0.00666	CbGpPWpGaD
Niclosamide—STAT3—epithelium—salivary gland cancer	0.00645	0.212	CbGeAlD
Niclosamide—STAT3—Signaling events mediated by TCPTP—CREBBP—salivary gland cancer	0.0061	0.00629	CbGpPWpGaD
Niclosamide—STAT3—Kit receptor signaling pathway—MAP2K2—salivary gland cancer	0.00601	0.0062	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—FGF16—salivary gland cancer	0.00599	0.00617	CbGpPWpGaD
Niclosamide—STAT3—Notch-mediated HES/HEY network—NOTCH1—salivary gland cancer	0.00591	0.0061	CbGpPWpGaD
Niclosamide—STAT3—IFN-gamma pathway—CREBBP—salivary gland cancer	0.00575	0.00594	CbGpPWpGaD
Niclosamide—STAT3—IL-6 signaling pathway—CREBBP—salivary gland cancer	0.00575	0.00594	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR1 fusion mutants—PIK3CA—salivary gland cancer	0.00557	0.00575	CbGpPWpGaD
Niclosamide—STAT3—Oncostatin M Signaling Pathway—MAP2K2—salivary gland cancer	0.00557	0.00574	CbGpPWpGaD
Niclosamide—STAT3—Androgen receptor signaling pathway—BRCA1—salivary gland cancer	0.00549	0.00567	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—FGF16—salivary gland cancer	0.00538	0.00555	CbGpPWpGaD
Niclosamide—STAT3—Notch-mediated HES/HEY network—CREBBP—salivary gland cancer	0.00536	0.00553	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by Stem cell factor receptor (c-Kit)—CREBBP—salivary gland cancer	0.00502	0.00518	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—FGF16—salivary gland cancer	0.00499	0.00515	CbGpPWpGaD
Niclosamide—STAT3—lymphoid tissue—salivary gland cancer	0.00497	0.163	CbGeAlD
Niclosamide—STAT3—Leptin signaling pathway—MAP2K2—salivary gland cancer	0.00496	0.00512	CbGpPWpGaD
Niclosamide—STAT3—Signaling of Hepatocyte Growth Factor Receptor—PTEN—salivary gland cancer	0.00496	0.00511	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—FGF16—salivary gland cancer	0.00488	0.00503	CbGpPWpGaD
Niclosamide—STAT3—Notch Signaling Pathway—NOTCH1—salivary gland cancer	0.0048	0.00495	CbGpPWpGaD
Niclosamide—STAT3—TGF-beta Receptor Signaling—CREBBP—salivary gland cancer	0.0048	0.00495	CbGpPWpGaD
Niclosamide—STAT3—RAC1 signaling pathway—CDH1—salivary gland cancer	0.00476	0.00491	CbGpPWpGaD
Niclosamide—STAT3—FGF signaling pathway—CDH1—salivary gland cancer	0.00476	0.00491	CbGpPWpGaD
Niclosamide—STAT3—MicroRNAs in cardiomyocyte hypertrophy—MAP2K2—salivary gland cancer	0.00453	0.00468	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—FGFR4—salivary gland cancer	0.00442	0.00456	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—FGF16—salivary gland cancer	0.00442	0.00456	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Leptin—HRAS—salivary gland cancer	0.00401	0.00414	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—CNTN6—salivary gland cancer	0.00401	0.00413	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—FGFR4—salivary gland cancer	0.00398	0.0041	CbGpPWpGaD
Niclosamide—STAT3—IFN-gamma pathway—EP300—salivary gland cancer	0.00392	0.00404	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by HDAC Class I—CREBBP—salivary gland cancer	0.0039	0.00402	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR1 mutants—PIK3CA—salivary gland cancer	0.00387	0.00399	CbGpPWpGaD
Niclosamide—STAT3—ErbB1 downstream signaling—MAP2K2—salivary gland cancer	0.00379	0.00391	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Interleukins—MAP2K2—salivary gland cancer	0.00371	0.00382	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—FGFR4—salivary gland cancer	0.00369	0.0038	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—FOXO3—salivary gland cancer	0.00367	0.00378	CbGpPWpGaD
Niclosamide—STAT3—Notch-mediated HES/HEY network—EP300—salivary gland cancer	0.00365	0.00376	CbGpPWpGaD
Niclosamide—STAT3—BDNF signaling pathway—FOXO3—salivary gland cancer	0.00361	0.00372	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—FGFR4—salivary gland cancer	0.0036	0.00372	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by Stem cell factor receptor (c-Kit)—PTEN—salivary gland cancer	0.00359	0.0037	CbGpPWpGaD
Niclosamide—STAT3—Signaling of Hepatocyte Growth Factor Receptor—PIK3CA—salivary gland cancer	0.0035	0.00361	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—FGF16—salivary gland cancer	0.0034	0.00351	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—NUP62—salivary gland cancer	0.00331	0.00342	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—FOXO3—salivary gland cancer	0.0033	0.0034	CbGpPWpGaD
Niclosamide—STAT3—PDGFR-beta signaling pathway—MAP2K2—salivary gland cancer	0.0033	0.0034	CbGpPWpGaD
Niclosamide—STAT3—GMCSF-mediated signaling events—PIK3CA—salivary gland cancer	0.00327	0.00337	CbGpPWpGaD
Niclosamide—STAT3—IL23-mediated signaling events—PIK3CA—salivary gland cancer	0.00327	0.00337	CbGpPWpGaD
Niclosamide—STAT3—IL-4 Signaling Pathway—EP300—salivary gland cancer	0.00327	0.00337	CbGpPWpGaD
Niclosamide—STAT3—TGF-beta Receptor Signaling—EP300—salivary gland cancer	0.00327	0.00337	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—FGFR4—salivary gland cancer	0.00326	0.00337	CbGpPWpGaD
Niclosamide—STAT3—Signaling of Hepatocyte Growth Factor Receptor—HRAS—salivary gland cancer	0.00324	0.00334	CbGpPWpGaD
Niclosamide—STAT3—Neurotrophic factor-mediated Trk receptor signaling—CCND1—salivary gland cancer	0.00322	0.00332	CbGpPWpGaD
Niclosamide—STAT3—Notch Signaling Pathway—CCND1—salivary gland cancer	0.00322	0.00332	CbGpPWpGaD
Niclosamide—STAT3—Androgen receptor signaling pathway—CREBBP—salivary gland cancer	0.00322	0.00332	CbGpPWpGaD
Niclosamide—CYP2C9—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.0032	0.0033	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by TCPTP—PIK3CA—salivary gland cancer	0.00307	0.00317	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—FOXO3—salivary gland cancer	0.00306	0.00315	CbGpPWpGaD
Niclosamide—STAT3—Kit receptor signaling pathway—EP300—salivary gland cancer	0.00304	0.00314	CbGpPWpGaD
Niclosamide—STAT3—GMCSF-mediated signaling events—HRAS—salivary gland cancer	0.00302	0.00312	CbGpPWpGaD
Niclosamide—STAT3—ErbB2/ErbB3 signaling events—PIK3CA—salivary gland cancer	0.00301	0.00311	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—MAP2K2—salivary gland cancer	0.003	0.00309	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—FOXO3—salivary gland cancer	0.00299	0.00309	CbGpPWpGaD
Niclosamide—STAT3—Notch Signaling Pathway—EP300—salivary gland cancer	0.00296	0.00306	CbGpPWpGaD
Niclosamide—STAT3—BDNF signaling pathway—MAP2K2—salivary gland cancer	0.00295	0.00304	CbGpPWpGaD
Niclosamide—STAT3—PDGF Pathway—HRAS—salivary gland cancer	0.0029	0.00299	CbGpPWpGaD
Niclosamide—STAT3—IFN-gamma pathway—PIK3CA—salivary gland cancer	0.0029	0.00299	CbGpPWpGaD
Niclosamide—STAT3—lymph node—salivary gland cancer	0.0028	0.0919	CbGeAlD
Niclosamide—STAT3—Signaling by FGFR mutants—PIK3CA—salivary gland cancer	0.0028	0.00288	CbGpPWpGaD
Niclosamide—STAT3—ErbB2/ErbB3 signaling events—HRAS—salivary gland cancer	0.00279	0.00287	CbGpPWpGaD
Niclosamide—STAT3—IL-2 Signaling Pathway—HRAS—salivary gland cancer	0.00273	0.00282	CbGpPWpGaD
Niclosamide—STAT3—Leptin signaling pathway—CCND1—salivary gland cancer	0.00273	0.00281	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—FOXO3—salivary gland cancer	0.00271	0.00279	CbGpPWpGaD
Niclosamide—STAT3—TSLP Signaling Pathway—PIK3CA—salivary gland cancer	0.0027	0.00278	CbGpPWpGaD
Niclosamide—STAT3—IL6-mediated signaling events—PIK3CA—salivary gland cancer	0.0027	0.00278	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—MAP2K2—salivary gland cancer	0.00269	0.00278	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—MAP2K2—salivary gland cancer	0.00268	0.00277	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by HDAC Class I—EP300—salivary gland cancer	0.00265	0.00274	CbGpPWpGaD
Niclosamide—STAT3—Interleukin-11 Signaling Pathway—HRAS—salivary gland cancer	0.00263	0.00272	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR mutants—HRAS—salivary gland cancer	0.00259	0.00267	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by Stem cell factor receptor (c-Kit)—PIK3CA—salivary gland cancer	0.00253	0.00261	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—FGFR4—salivary gland cancer	0.00251	0.00259	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—MAP2K2—salivary gland cancer	0.0025	0.00258	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by PTP1B—PIK3CA—salivary gland cancer	0.00249	0.00257	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—MAP2K2—salivary gland cancer	0.00244	0.00252	CbGpPWpGaD
Niclosamide—STAT3—IL-4 Signaling Pathway—PIK3CA—salivary gland cancer	0.00242	0.00249	CbGpPWpGaD
Niclosamide—STAT3—FGF signaling pathway—PIK3CA—salivary gland cancer	0.00242	0.00249	CbGpPWpGaD
Niclosamide—STAT3—IL2-mediated signaling events—PIK3CA—salivary gland cancer	0.00242	0.00249	CbGpPWpGaD
Niclosamide—STAT3—IL-3 Signaling Pathway—HRAS—salivary gland cancer	0.00242	0.00249	CbGpPWpGaD
Niclosamide—STAT3—Androgen receptor signaling pathway—CCND1—salivary gland cancer	0.00238	0.00245	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by Stem cell factor receptor (c-Kit)—HRAS—salivary gland cancer	0.00234	0.00241	CbGpPWpGaD
Niclosamide—STAT3—Androgen receptor signaling pathway—PTEN—salivary gland cancer	0.0023	0.00237	CbGpPWpGaD
Niclosamide—STAT3—IL2-mediated signaling events—HRAS—salivary gland cancer	0.00224	0.00231	CbGpPWpGaD
Niclosamide—STAT3—TGF-beta Receptor Signaling—HRAS—salivary gland cancer	0.00224	0.00231	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—MAP2K2—salivary gland cancer	0.00221	0.00228	CbGpPWpGaD
Niclosamide—STAT3—Neurotrophic factor-mediated Trk receptor signaling—PIK3CA—salivary gland cancer	0.00219	0.00226	CbGpPWpGaD
Niclosamide—STAT3—Androgen receptor signaling pathway—EP300—salivary gland cancer	0.00219	0.00226	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—FOXO3—salivary gland cancer	0.00208	0.00215	CbGpPWpGaD
Niclosamide—STAT3—Kit receptor signaling pathway—HRAS—salivary gland cancer	0.00208	0.00215	CbGpPWpGaD
Niclosamide—STAT3—TSH signaling pathway—PIK3CA—salivary gland cancer	0.00206	0.00212	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—ATM—salivary gland cancer	0.00205	0.00212	CbGpPWpGaD
Niclosamide—STAT3—Rac1/Pak1/p38/MMP-2 pathway—PIK3CA—salivary gland cancer	0.00203	0.0021	CbGpPWpGaD
Niclosamide—STAT3—Neurotrophic factor-mediated Trk receptor signaling—HRAS—salivary gland cancer	0.00203	0.00209	CbGpPWpGaD
Niclosamide—STAT3—Oncostatin M Signaling Pathway—TP53—salivary gland cancer	0.00202	0.00208	CbGpPWpGaD
Niclosamide—STAT3—Rac1/Pak1/p38/MMP-2 pathway—TP53—salivary gland cancer	0.00197	0.00203	CbGpPWpGaD
Niclosamide—STAT3—Oncostatin M Signaling Pathway—HRAS—salivary gland cancer	0.00193	0.00199	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00192	0.00198	CbGpPWpGaD
Niclosamide—STAT3—TSH signaling pathway—HRAS—salivary gland cancer	0.0019	0.00196	CbGpPWpGaD
Niclosamide—STAT3—Rac1/Pak1/p38/MMP-2 pathway—HRAS—salivary gland cancer	0.00188	0.00194	CbGpPWpGaD
Niclosamide—STAT3—Disease—WNT5B—salivary gland cancer	0.00183	0.00189	CbGpPWpGaD
Niclosamide—STAT3—Disease—PYGB—salivary gland cancer	0.00177	0.00182	CbGpPWpGaD
Niclosamide—STAT3—Disease—IL17RD—salivary gland cancer	0.00177	0.00182	CbGpPWpGaD
Niclosamide—STAT3—Disease—CPSF4—salivary gland cancer	0.00177	0.00182	CbGpPWpGaD
Niclosamide—STAT3—PDGFR-beta signaling pathway—PTEN—salivary gland cancer	0.00175	0.00181	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—MAP2K2—salivary gland cancer	0.00173	0.00178	CbGpPWpGaD
Niclosamide—STAT3—Leptin signaling pathway—HRAS—salivary gland cancer	0.00172	0.00177	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—MAP2K2—salivary gland cancer	0.0017	0.00175	CbGpPWpGaD
Niclosamide—STAT3—MicroRNAs in cardiomyocyte hypertrophy—PIK3CA—salivary gland cancer	0.0017	0.00175	CbGpPWpGaD
Niclosamide—STAT3—CXCR4-mediated signaling events—PIK3CA—salivary gland cancer	0.0017	0.00175	CbGpPWpGaD
Niclosamide—STAT3—Disease—MAML3—salivary gland cancer	0.00162	0.00167	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—PTEN—salivary gland cancer	0.00159	0.00164	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—ATM—salivary gland cancer	0.00155	0.0016	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—PTEN—salivary gland cancer	0.00143	0.00147	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—PTEN—salivary gland cancer	0.00142	0.00147	CbGpPWpGaD
Niclosamide—STAT3—ErbB1 downstream signaling—PIK3CA—salivary gland cancer	0.00142	0.00146	CbGpPWpGaD
Niclosamide—STAT3—Disease—ST3GAL4—salivary gland cancer	0.00139	0.00143	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Interleukins—PIK3CA—salivary gland cancer	0.00139	0.00143	CbGpPWpGaD
Niclosamide—STAT3—Immune System—DTX4—salivary gland cancer	0.00137	0.00141	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—CREBBP—salivary gland cancer	0.00135	0.00139	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—FOXO3—salivary gland cancer	0.00135	0.00139	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—PTEN—salivary gland cancer	0.00132	0.00137	CbGpPWpGaD
Niclosamide—STAT3—ErbB1 downstream signaling—HRAS—salivary gland cancer	0.00131	0.00135	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—PTEN—salivary gland cancer	0.0013	0.00134	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Interleukins—HRAS—salivary gland cancer	0.00128	0.00132	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—WNT5B—salivary gland cancer	0.00128	0.00132	CbGpPWpGaD
Niclosamide—STAT3—Disease—DTX4—salivary gland cancer	0.00126	0.0013	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IL17RD—salivary gland cancer	0.00124	0.00128	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CYLD—salivary gland cancer	0.00123	0.00127	CbGpPWpGaD
Niclosamide—STAT3—PDGFR-beta signaling pathway—PIK3CA—salivary gland cancer	0.00123	0.00127	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PRKDC—salivary gland cancer	0.00118	0.00122	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—PTEN—salivary gland cancer	0.00117	0.00121	CbGpPWpGaD
Niclosamide—STAT3—PDGFR-beta signaling pathway—HRAS—salivary gland cancer	0.00114	0.00118	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MAML3—salivary gland cancer	0.00113	0.00117	CbGpPWpGaD
Niclosamide—STAT3—Immune System—FGF16—salivary gland cancer	0.00113	0.00116	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—PIK3CA—salivary gland cancer	0.00112	0.00116	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—MAP2K2—salivary gland cancer	0.0011	0.00113	CbGpPWpGaD
Niclosamide—STAT3—Immune System—NUP62—salivary gland cancer	0.00108	0.00112	CbGpPWpGaD
Niclosamide—STAT3—Disease—FGF16—salivary gland cancer	0.00104	0.00108	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—HRAS—salivary gland cancer	0.00104	0.00107	CbGpPWpGaD
Niclosamide—STAT3—BDNF signaling pathway—HRAS—salivary gland cancer	0.00102	0.00105	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MC3R—salivary gland cancer	0.00101	0.00104	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—PIK3CA—salivary gland cancer	0.00101	0.00104	CbGpPWpGaD
Niclosamide—STAT3—Disease—NUP62—salivary gland cancer	0.001	0.00103	CbGpPWpGaD
Niclosamide—STAT3—Disease—VCAN—salivary gland cancer	0.000992	0.00102	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000972	0.001	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—PIK3CA—salivary gland cancer	0.000935	0.000964	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—HRAS—salivary gland cancer	0.000933	0.000962	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—HRAS—salivary gland cancer	0.000928	0.000957	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—EP300—salivary gland cancer	0.000918	0.000947	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—PIK3CA—salivary gland cancer	0.000914	0.000943	CbGpPWpGaD
Niclosamide—STAT3—Disease—MAML2—salivary gland cancer	0.000906	0.000934	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—PTEN—salivary gland cancer	0.000903	0.000931	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—NOTCH1—salivary gland cancer	0.0009	0.000929	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—DTX4—salivary gland cancer	0.000883	0.000911	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—TP53—salivary gland cancer	0.000869	0.000896	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—HRAS—salivary gland cancer	0.000865	0.000892	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—HRAS—salivary gland cancer	0.000846	0.000872	CbGpPWpGaD
Niclosamide—STAT3—Immune System—FGFR4—salivary gland cancer	0.000834	0.00086	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—PIK3CA—salivary gland cancer	0.000828	0.000854	CbGpPWpGaD
Niclosamide—STAT3—Immune System—FBXW7—salivary gland cancer	0.000821	0.000846	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—CREBBP—salivary gland cancer	0.000816	0.000842	CbGpPWpGaD
Niclosamide—STAT3—Disease—JAG1—salivary gland cancer	0.000773	0.000798	CbGpPWpGaD
Niclosamide—STAT3—Disease—FGFR4—salivary gland cancer	0.00077	0.000794	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—HRAS—salivary gland cancer	0.000766	0.00079	CbGpPWpGaD
Niclosamide—STAT3—Disease—FBXW7—salivary gland cancer	0.000758	0.000781	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—FGF16—salivary gland cancer	0.00073	0.000753	CbGpPWpGaD
Niclosamide—STAT3—Immune System—FOXO3—salivary gland cancer	0.000692	0.000714	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—TP53—salivary gland cancer	0.000657	0.000677	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—PIK3CA—salivary gland cancer	0.000648	0.000668	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—EP300—salivary gland cancer	0.000645	0.000665	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—salivary gland cancer	0.000645	0.000665	CbGpPWpGaD
Niclosamide—STAT3—Disease—FOXO3—salivary gland cancer	0.000639	0.000659	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—PIK3CA—salivary gland cancer	0.000637	0.000657	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MAML2—salivary gland cancer	0.000634	0.000654	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—HRAS—salivary gland cancer	0.000599	0.000618	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—HRAS—salivary gland cancer	0.000589	0.000608	CbGpPWpGaD
Niclosamide—STAT3—Immune System—MAP2K2—salivary gland cancer	0.000565	0.000583	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—EP300—salivary gland cancer	0.000556	0.000573	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—JAG1—salivary gland cancer	0.000542	0.000559	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—FGFR4—salivary gland cancer	0.000539	0.000556	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—FBXW7—salivary gland cancer	0.000531	0.000547	CbGpPWpGaD
Niclosamide—STAT3—Disease—MAP2K2—salivary gland cancer	0.000522	0.000538	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—FOXO3—salivary gland cancer	0.000448	0.000462	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—salivary gland cancer	0.000441	0.000455	CbGpPWpGaD
Niclosamide—STAT3—Disease—NOTCH1—salivary gland cancer	0.000428	0.000441	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CREBBP—salivary gland cancer	0.00042	0.000433	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CDH1—salivary gland cancer	0.000417	0.00043	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ISYNA1—salivary gland cancer	0.000397	0.00041	CbGpPWpGaD
Niclosamide—STAT3—Disease—CREBBP—salivary gland cancer	0.000388	0.0004	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—HRAS—salivary gland cancer	0.00038	0.000392	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MAP2K2—salivary gland cancer	0.000365	0.000377	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ISYNA1—salivary gland cancer	0.000339	0.00035	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—MARCKS—salivary gland cancer	0.000324	0.000334	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PYGB—salivary gland cancer	0.000301	0.00031	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PTEN—salivary gland cancer	0.0003	0.000309	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—NOTCH1—salivary gland cancer	0.000299	0.000309	CbGpPWpGaD
Niclosamide—STAT3—Immune System—EP300—salivary gland cancer	0.000286	0.000295	CbGpPWpGaD
Niclosamide—STAT3—Disease—PTEN—salivary gland cancer	0.000277	0.000286	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—MARCKS—salivary gland cancer	0.000277	0.000285	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CREBBP—salivary gland cancer	0.000271	0.00028	CbGpPWpGaD
Niclosamide—STAT3—Disease—EP300—salivary gland cancer	0.000264	0.000272	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PYGB—salivary gland cancer	0.000257	0.000265	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PHGDH—salivary gland cancer	0.000245	0.000253	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ST3GAL4—salivary gland cancer	0.000236	0.000244	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—AQP1—salivary gland cancer	0.000214	0.000221	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PIK3CA—salivary gland cancer	0.000212	0.000218	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PHGDH—salivary gland cancer	0.00021	0.000216	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ST3GAL4—salivary gland cancer	0.000202	0.000208	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCND1—salivary gland cancer	0.000201	0.000207	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HRAS—salivary gland cancer	0.000196	0.000202	CbGpPWpGaD
Niclosamide—STAT3—Disease—PIK3CA—salivary gland cancer	0.000195	0.000201	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PTEN—salivary gland cancer	0.000194	0.0002	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—EP300—salivary gland cancer	0.000185	0.000191	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—AQP1—salivary gland cancer	0.000183	0.000189	CbGpPWpGaD
Niclosamide—STAT3—Disease—HRAS—salivary gland cancer	0.000181	0.000186	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—NUP62—salivary gland cancer	0.00017	0.000175	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—VCAN—salivary gland cancer	0.000169	0.000174	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000148	0.000153	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—NUP62—salivary gland cancer	0.000145	0.00015	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—VCAN—salivary gland cancer	0.000144	0.000149	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PIK3CA—salivary gland cancer	0.000137	0.000141	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—TP53—salivary gland cancer	0.000132	0.000136	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000127	0.000131	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—HRAS—salivary gland cancer	0.000127	0.000131	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000106	0.000109	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000101	0.000104	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	9.04e-05	9.32e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	8.62e-05	8.89e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	7.46e-05	7.7e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CREBBP—salivary gland cancer	6.6e-05	6.8e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	6.38e-05	6.58e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CREBBP—salivary gland cancer	5.64e-05	5.81e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PTEN—salivary gland cancer	4.71e-05	4.86e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—EP300—salivary gland cancer	4.49e-05	4.63e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PTEN—salivary gland cancer	4.03e-05	4.15e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—EP300—salivary gland cancer	3.84e-05	3.96e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PIK3CA—salivary gland cancer	3.32e-05	3.43e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PIK3CA—salivary gland cancer	2.84e-05	2.93e-05	CbGpPWpGaD
